glp-1 receptor agonists for weight loss Agonists: A Comprehensive Overview Cardiovascular Protective Properties of GLP-1

Hypoxic conditions can also lead to a phenomenon known as DPP-4 shedding whereby transmembrane DPP-4 is cleaved from the membrane and released into the circulation in a soluble form

Brown A, McArdle P, Taplin J, Unwin D, Unwin J, Deakin T, et al

(Abstract) J Med Toxicol 2023:19(2):63-168

Other compounds in the pipeline include survodutide , mazdutide , CagriSema , and orforglipron

As our knowledge of GLP-1 biology advances and novel therapeutic innovations arise, these agents are expected to assume a progressively pivotal role in the management of metabolic disorders and their related complications, ultimately enhancing patient outcomes across various disease states

D.C., S.W., J.G., Y.L., Z.Z., J.K.: Visualization, Resources